Health Canada has approved Actonel(R) (risedronate sodium tablets) 150 mg, Canada's first and only once-a-month dosing option in the treatment of postmenopausal osteoporosis. Canadian patients at high risk of osteoporotic fracture now have the convenience of taking one tablet on the same day each month.